Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
Let’s move on , we have 2 years of cash to play with, the scumbags rinsed the company & no doubt they will try again. but we will hopefully help cancer sufferers & make more money in the process, arguing about anything doesn’t matter anymore, you either believe in avacta or you don’t, am still having a drink 🥂
68 million shares in 2016 & we all had a dream ( Martin Luther ) end of 2024 / start of 2025 , 300 million shares , ( don’t forget HCI shares repayments ) & we are all very rich & happy , & a safe cancer treatment for all , not a hard conclusion 🥂
What about his infamous quote on 16/12/22
“avacta not going anywhere, anytime soon “ & he sold at 99p , to buy HARL @ 21p , 8 weeks later avacta was 80% up lol :-)
& harl halved , can’t wait for this year’s anniversary quote :-)
Wearegrout , 30 minutes in , on financial results , allistar says there will present some news on ava028 pdl il 15 , in a couple of weeks, so that could be positive news flow / think a RNS will be attached to it
Love this in uk investor magazine
The drug was well tolerated by patients despite receiving nearly 3 times the typical dose of chemotherapy drug doxorubicin. Importantly, the toxicities associated with doxorubicin were not observed.